Entera Bio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Entera Bio Ltd. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue0.180.000.130.570.370.240.50
Cost of Revenue0.170.000.100.370.30-0.210.00
Gross Profit0.010.000.030.200.070.030.50
Operating Expenses
Research & Development4.504.515.856.776.387.208.52
Selling, General & Administrative5.104.437.255.694.854.282.84
Operating Expenses9.598.8913.0512.4211.2311.4811.36
Operating Income-9.59-8.89-13.02-12.22-11.17-11.45-10.86
Other Income/Expense
Interest Income0.060.030.000.000.000.000.00
Interest Expense0.000.000.000.03-0.030.000.00
Other Income/Expense0.06-0.080.080.36-1.24-0.740.52
Income
Income Before Tax-9.53-8.86-12.93-12.25-11.20-10.80-10.30
Income Tax Expense0.010.030.14-0.060.020.000.00
Net Income-9.54-8.89-13.07-12.19-11.22-10.80-10.30
Net Income - Continuous Operations-9.54-8.89-13.07-12.190.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA-9.54-8.84-12.95-12.16-11.11-10.80-10.81
EBIT-9.59-8.89-13.02-12.22-11.17-10.80-10.86
Depreciation & Amortization0.050.060.060.050.060.000.00
Earnings Per Share
Basic EPS-----1.001.00-1.00
Diluted EPS-----1.001.00-1.00
Basic Shares Outstanding37.6529.0128.8126.1318.4212.157.96
Diluted Shares Outstanding37.6529.0128.8126.1318.4212.137.98